‘Surprise’ prostate result probed
June 21st, 2009 Posted in prostate cancerResearchers are probing an unexpected success in a study of an experimental treatment for prostate cancer.
In three men with advanced disease, use of an immune drug called ipilimumab, shrank their tumours to such an extent surgeons were able to operate. The Mayo Clinic team in the US said the “startling” results in the study of 108 men had prompted them to set up a second trial using higher doses. One UK expert said there were currently few treatments for advanced disease.
In men with advanced prostate cancer, which has spread outside the prostate, surgery cannot usually be done.